Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching.

Results indicate high likelihood that antibody cocktails were consistently associated with high probability of survival, although low likelihood was found for other drugs for older patients with mild to severe severity and all age patients with moderate severity. Further study is necessary in light of the lack of available data.